GSA Capital Partners LLP Invests $434,000 in Core Laboratories Inc. (NYSE:CLB)

GSA Capital Partners LLP purchased a new position in shares of Core Laboratories Inc. (NYSE:CLB) during the third quarter, Holdings Channel reports. The institutional investor purchased 23,400 shares of the oil and gas company’s stock, valued at approximately $434,000.

Other hedge funds have also recently made changes to their positions in the company. Headlands Technologies LLC purchased a new stake in shares of Core Laboratories during the 2nd quarter worth $36,000. nVerses Capital LLC purchased a new stake in shares of Core Laboratories during the 3rd quarter worth $48,000. GAMMA Investing LLC raised its stake in Core Laboratories by 23.9% in the second quarter. GAMMA Investing LLC now owns 4,425 shares of the oil and gas company’s stock valued at $90,000 after buying an additional 855 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in Core Laboratories by 11.9% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 5,636 shares of the oil and gas company’s stock valued at $114,000 after buying an additional 600 shares during the last quarter. Finally, Signaturefd LLC raised its stake in Core Laboratories by 12.8% in the second quarter. Signaturefd LLC now owns 6,776 shares of the oil and gas company’s stock valued at $137,000 after buying an additional 767 shares during the last quarter. 97.81% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CLB has been the subject of several research analyst reports. Citigroup reduced their price objective on Core Laboratories from $15.00 to $14.00 and set a “sell” rating for the company in a research note on Thursday, October 31st. StockNews.com raised Core Laboratories from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Finally, Stifel Nicolaus raised their price objective on Core Laboratories from $18.00 to $22.00 and gave the company a “hold” rating in a report on Friday, July 26th. Two investment analysts have rated the stock with a sell rating and three have given a hold rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $17.00.

Core Laboratories Trading Up 2.6 %

CLB opened at $20.32 on Thursday. Core Laboratories Inc. has a 12 month low of $13.82 and a 12 month high of $25.13. The stock has a market capitalization of $954.02 million, a price-to-earnings ratio of 31.26, a PEG ratio of 1.36 and a beta of 2.35. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.48 and a quick ratio of 1.79. The business has a fifty day moving average price of $19.09 and a 200 day moving average price of $19.37.

Core Laboratories (NYSE:CLB) last released its quarterly earnings data on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.04. Core Laboratories had a return on equity of 15.84% and a net margin of 5.83%. The business had revenue of $134.40 million during the quarter, compared to analysts’ expectations of $134.16 million. During the same period in the prior year, the firm posted $0.22 EPS. The business’s quarterly revenue was up 7.2% compared to the same quarter last year. Sell-side analysts expect that Core Laboratories Inc. will post 0.77 earnings per share for the current fiscal year.

Core Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 25th. Shareholders of record on Monday, November 4th will be given a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.20%. The ex-dividend date of this dividend is Monday, November 4th. Core Laboratories’s payout ratio is 6.15%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.